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Abstract
Variants in the KIF1A gene can cause autosomal recessive spastic paraplegia 30, autosomal recessive hereditary sensory
neuropathy, or autosomal (de novo) dominant mental retardation type 9. More recently, variants in KIF1A have also been
described in a few cases with autosomal dominant spastic paraplegia. Here, we describe 20 KIF1A variants in 24 patients
from a clinical exome sequencing cohort of 347 individuals with a mostly ‘pure’ spastic paraplegia. In these patients, spastic
paraplegia was slowly progressive and mostly pure, but with a highly variable disease onset (0–57 years). Segregation
analyses showed a de novo occurrence in seven cases, and a dominant inheritance pattern in 11 families. The motor domain
of KIF1A is a hotspot for disease causing variants in autosomal dominant spastic paraplegia, similar to mental retardation
type 9 and recessive spastic paraplegia type 30. However, unlike these allelic disorders, dominant spastic paraplegia was also
caused by loss-of-function variants outside this domain in six families. Finally, three missense variants were outside the
motor domain and need further characterization. In conclusion, KIF1A variants are a frequent cause of autosomal dominant
spastic paraplegia in our cohort (6–7%). The identification of KIF1A loss-of-function variants suggests haploinsufficiency as
a possible mechanism in autosomal dominant spastic paraplegia.
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Introduction
Hereditary spastic paraplegia (HSP) is a neurodegenera-
tive disorder that affects motor control over the lower
limbs and the bladder, with an incidence of ~1–10 per
100,000 individuals [1]. In the pure form, patients suffer
from lower extremity spasticity and weakness and often
from urinary urgency. In complicated forms, HSP may be
associated with additional neurologic abnormalities, such
as intellectual disability, peripheral neuropathy, ataxia,
distal muscle wasting, and optic neuropathy [2]. HSP may
follow a (de novo) autosomal dominant, autosomal
recessive, X-linked, or mitochondrial inheritance pattern.
At this moment, 79 loci and 61 corresponding genes have
been associated with HSP [3]. The most common auto-
somal dominant HSP is spastic paraplegia (SPG) type 4,
caused by a variant in the SPAST gene (40%), while SPG7
and SPG11 variants are the most frequent causes of
recessive forms.
Variants in KIF1A have been described in three different
disorders in OMIM. The first is autosomal recessive her-
editary sensory neuropathy IIC (MIM # 614213) that has
been described in four families. All families had the same
frameshift variant that resides in an alternative transcript
(NM_001244008.1/NP_001230937.1), suggesting that
absence of that alternative transcript was the cause of her-
editary sensory neuropathy IIC [4]. The second is autosomal
dominant mental retardation type 9 (MIM # 614255), which
is characterized by severe cognitive impairment with spastic
paraparesis, axonal neuropathy, epilepsy and/or cerebellar
atrophy. At least 17 de novo missense variants affecting the
kinesin motor domain of KIF1A have been described in this
syndrome [5–8]. Functional analyses suggested a dominant-
negative effect of these missense variants on the movement
of this kinesin along the microtubules. The third disorder
associated with KIF1A is autosomal recessive SPG type 30
(MIM#610357), characterized by slowly progressive pure
HSP with an onset in the first or second decade. Missense
variants in the kinesin domain of KIF1A are responsible for
the three autosomal recessive SPG30 families described to
date [9, 10].
A few reports of autosomal dominant SPG make up for a
possible fourth disorder, not yet described in OMIM,
associated with KIF1A [11–13]. Similar to dominant mental
retardation type 9 and recessive SPG30, all currently
reported KIF1A variants in dominant, pure HSP were also
missense variants affecting the kinesin motor domain, with
the exception of one variant of uncertain significance.
By exome sequencing, we identified variants in the
KIF1A gene in 24 out of 347 probands with SPG. Variants
are not only missense variants in the motor domain of
KIF1A, but also loss-of-function variants outside this
domain, expanding the spectrum of variants.
Subjects and methods
Editorial policies and ethical consideration
Clinical exome sequencing was approved by the Medical
Review Ethics Committee, Region Arnhem–Nijmegen,
Number 2011/188. All human subjects provided informed
consent for this study.
Patients
Patients with HSP from The Netherlands (80%) and other
European countries (20%) were included in clinical exome
sequencing as part of their diagnostic work-up. No restric-
tions on age at onset or inheritance pattern were made, but
there had to be a clinical suspicion of a genetic etiology. All
patients were counseled by a clinical geneticist or neurol-
ogist. From each family, only one patient (proband) was
included for exome sequencing. Candidate variants were
verified by Sanger sequencing in affected family members
whenever possible.
Previous gene testing in some probands of the families
presented here excluded the most common forms of auto-
somal dominant SPG, types 4 and 3A, caused by variants in
the SPAST gene (13/24 probands) or the ATL1 gene (7/24
probands), respectively.
Available clinical and imaging data of the probands and
affected family members (30 in total) were systematically
collected and reviewed.
Exome sequencing and data analysis
Exome sequencing was performed as previously described
[14]. In summary, capture of exons was done using an Agilent
SureSelect Human All Exon 50Mb Kit (Santa Clara, CA,
USA). Sequencing was performed using a LifeTechnologies
5500XL machine (Thermo Fisher, Waltham, MA, USA) or an
Illumina Hiseq 2000 or 4000 (San Diego, CA, USA). Read
mapping and variant calling were done using LifeScope Life
Technologies (Thermo Fisher) for the 5500XL data or BWA
(mapping) and GATK (calling) for the Illumina data. A filter
for a ‘movement disorders’ gene panel was applied. This
panel consists of ∼300 genes implicated in various forms of
cerebellar ataxia, HSP, genetic choreas, and other hyperkinetic
movement disorders [15] and is available from our website
(https://www.radboudumc.nl/en/patientenzorg/onderzoeken/
exome-sequencing-diagnostics/exomepanelspreviousversions/
movement-disorders). The single nucleotide variant data were
filtered by [1] frequency (<5% dbSNP, <1% in house data-
base, gnomAD, EXAC [16]) [2] nucleotide and amino acid
conservation and [3] exon/intronic position (−20 till +8).
Accession number NM_004321.7 and HGVS were used for
nomenclature of variants in the KIF1A gene. The likelihood of
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the disease causing effect of these variants was based on
frequencies (absence) in control populations, evolutionary
conservation, and segregation analyses. The KIF1A variants
described in this paper were submitted to LOVD (https://data
bases.lovd.nl/shared/genes/KIF1A).
Copy number variant (CNV) analyses from the WES
data were done as described [17]. Essentially, it was done
using CoNIFER (http://conifer.sourceforge.net/) [18].
CNVs with an absolute Z-score >1.7 were considered
for analysis. To reduce false calls due to potential batch
effects, analyses are performed using the most recent
samples as controls. CNVs were annotated based on the
number of RefSeq exons affected, frequency of CNVs
within the cohort, and overlap with disease genes from the
movement disorders gene panel. Sanger sequencing was
used to confirm the presence of the identified variants if
the quality score (from GATK) was not sufficient (<500).
In addition, Sanger sequencing was used for segregation




A cohort of 347 probands with a predominantly (>90%)
pure SPG was referred to our expert centre for ‘genetic
movement disorders’. Clinical exome sequencing was per-
formed as described [14]. Twenty different heterozygous
KIF1A variants were detected in 24 probands (Table 1 and
Fig. 1). One of those variants (in family 24) was a chro-
mosome 2q37 contiguous gene deletion including the entire
KIF1A gene (Chr2 [GRCh37]:g.(238475818_238482964)_
Table 1 KIF1A variants in autosomal dominant HSP







P1 c.89T>C; p.(Met30Thr) Motor 26.4 0/0 M, F, DM 00225586
P2 c.167A>G; p.(Tyr56Cys) Motor 28.6 0/0 M, F, DM, CE 00225587
P3 c.206C>T; p.(Ser69Leu) Motor 16.3 0/0 M 00246956
P4 c.221A>G; p.(Tyr74Cys)a Motor 25.7 0/0 M, F, DM, CE 00225589
P5 c.232G>A; p.(Gly78Ser) Motor 34 0/0 M, F, DM, CE 00225590
P6 c.317C>A; p.(Thr106Asn) Motor 26.3 0/0 M, F, DM, CE 00225591
P7 c.500G>A; p.(Arg167His) Motor 34 0/0 M, F, DM, CE 00225592
P8 c.518T>C; p.(Leu173Pro) Motor 27 0/0 M, F, DM, CE 00225593
P9/10 c.756C>G; p.(Ser252Arg) Motor 25.1 0/0 M, F, DM, CE 00225594
00246690
P11/12/13 c.773C>T; p.(Thr258Met) Motor 28.5 0/0 M, F, DM, CE 00225610
00246691
00246692
P14 c.1048C>T; p.(Arg350Trp) Motor 12.95 0/0 M, F, DM, CE 00225611
P15 c.1379C>G; p.(Ala460Gly) Coiled coil 25.3 0/0 M, F 00225612
P16 c.1867C>T; p.(Gln623*) ni 38 0/0 ni 00225613
P17/18 c.2527C>T; p.(Arg843Cys) – 35 1/244238 M, F 00225614
00246693
P19 c.2577C>A; p.(Asn859Lys) – 28.9 0/0 M, F, DM, CE 00225615
P20 c.3975C>G; p.(Tyr1325*) ni 29.1 0/0 ni 00225616
P21 c.4096_4103dup; (p.(Asp1369fs) ni 11.05 0/0 ni 00343920
P22 c.4292del; p.(Pro1431fs) ni 22.5 0/0 M, F 00225617
P23 c.4740dup; p.(Tyr1581fs) ni 35 0/0 ni 00225618
P24 Chr2[GRCh37]:g.(238475818_
238482964)_(243037178_qter)del
ni ni ni ni 00245206
Variants are described according to HGVS nomenclature. Protein domains are according to UniProt consortium (https://www.uniprot.org). Due to
nonsense-mediated decay domain of loss-of-function variants are not informative (ni). CADD scores (vs 1.3) and population frequencies were
obtained through https://cadd.gs.washington.edu/ and http://exac.broadinstitute.org, respectively. Conservation was determined using ensemble
alignments
M mammals, F fish, DM Drosophila melanogaster, CE C.elegans, ni not informative
aThis family has been described [15]
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(243037178_qter)del, Supplemental Fig.). Throughout the
remainder of the paper, the variants are discussed by the
protein change deduced from their DNA change. Three
variants were recurrent, p.(Ser252Arg) in two, p.
(Thr258Met) in three, and p.(Arg843Cys) in two families.
Targeted sequencing of the KIF1A gene was subsequently
performed to exclude putative bi-allelic variants, rendering
a possible recessive inheritance unlikely. All KIF1A var-
iants were absent from an in-house database of >30,000
clinical exomes, and from large sequencing cohorts in
gnomAD [16], except for the p.(Arg843Cys) variant that
was heterozygously present in one individual in gnomAD.
In addition, missense variants were of evolutionary con-
served amino acids (in all vertebrates and many even in
lower species; Table 1). Two variants, p.(Ser69Leu) and p.
(Thr258Met), were reported previously in autosomal
dominant HSP [11, 13]. No overlap was seen with the
KIF1A variants reported in the allelic disorders autosomal
recessive hereditary sensory neuropathy IIC, autosomal
dominant mental retardation type 9, or autosomal recessive
SPG30.
De novo and inherited autosomal dominant KIF1A variants
In 7 of the 24 patients, the KIF1A variants (p.(Gly78Ser),
p.(Thr106Asn), p.(Thr258Met) in three families,
(Tyr1581fs) and the Chr2q37 deletion) had occurred de
novo in the first affected generation (Fig. 2; P5, P6, P11,
P12, P13, P23, and P24), which was revealed by parental
testing including a paternity test. Eleven variants, including
one that was de novo in the first generation, were detected
in multiple affected family members in multiple generations
(P2, P3, P4, P8, P11, P15, P16, P17, P20, P21, and P22),
though families usually were small (Fig. 2). In four families
(P1, P7, P9, P14), a dominant inheritance was evident, but
family members refrained from testing or were deceased.
The remaining three probands did not have affected family
members and parents were unavailable for testing for de
novo occurrence (P10, P18, and P19).
Variants in the KIF1A gene in- and outside the kinesin
motor domain
Variants causing autosomal dominant mental retardation
type 9 or SPG30 invariably are missense variants located in
the kinesin motor domain of the KIF1A protein (Fig. 3), an
important domain for ‘walking’ of the kinesin along
microtubules. Functional analyses revealed a dominant-
negative effect of these variants in transport along micro-
tubules [5]. Eleven of the twenty variants in this study were
also missense variants located in this motor domain (Figs. 1
and 3), suggesting that these variants cause dominant SPG.
However, another nine variants were detected outside the
motor domain. In contrast to the motor domain variants,
six of the variants outside the domain are considered
loss-of-function variants (p.(Gly623)*, p.(Tyr1325*),
p.(Asp1369fs), p.(Pro1431fs), p.(Tyr1581fs), and the
Chr2q37 deletion including KIF1A). Two of the loss-of-
function variants were shown to be de novo occurrences
(P23 and P24) and the four others (P16, P20, P21, and P22)
Fig. 1 Schematic representation of the KIF1A protein with variants in
dominant spastic paraplegia. Variants identified in this study are
depicted above the schematic protein, isoform NP_004312.2, while
previously described variants in autosomal dominant spastic
paraplegia [11–13, 15, 29–32] are shown below the schematic. Protein
domains are according to UniProt consortium (https://www.uniprot.
org), with kinesin motor, cc coiled coil, FHA forkhead-associated, PH
pleckstrin homology domains. aThis family has been described [15]
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Fig. 2 Pedigrees of the 24 families with HSP. Generations are given in
Roman numbers, circles are females, squares are males, solid symbols
are affected individuals. Deceased individuals are crossed out. Var-
iants are indicated above the pedigree’s by protein nomenclature and
indicated by variant (+) and wild type (−) under each tested indivi-
dual. Arrows indicate the probands. The full HGVS nomenclature of
the Chr2q37 deletion is Chr2[GRCh37]:g.(238475818_238482964)_
(243037178_qter)del
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were present in multiple affected family members. Alto-
gether, these data indicate that loss-of function variants in
the KIF1A gene may also cause autosomal dominant SPG.
Finally, three of the nine variants outside the motor
domain were missense variants. In these families, segrega-
tion analyses were limited to two affected individuals (P15
and P17) or could not be performed since family members
refrained from testing, or were deceased (P18 and P19).
Clinical findings
The clinical characteristics of 24 probands and six affected
family members from families P3, P11, P20, and P21 were
analyzed. The overall picture is that of a slowly progressive,
pure HSP (Table 2, probands only). Age at onset was highly
variable, between 0 and 57 years, although the majority (17/
30) presented before age 11 years and only 3/30 after age 40
years. Progression was slow, evidenced by the fact that 25
of 30 patients walked unassisted despite disease durations
of over 40 years in some. All had lower limb spasticity
accompanied by pyramidal reflex patterns. Deep sensory
disturbances in the lower limbs were observed in 11/30,
distal and/or proximal leg weakness in 13/30 (accompanied
by leg muscle atrophy in some), and sphincter problems
were mentioned by 11/30. Arm involvement was seen in 11
patients, but mostly consisted of (slightly) increased tendon
reflexes, with occasional increased tone or a postural tre-
mor. Two patients also displayed primitive reflexes. Pes
cavovarus (tendency) was observed in 4/30 patients, and
spinal deformities (increased lumbar lordosis and thoracic
scoliosis) in 3/30. With regard to psychiatric comorbidity,
ADHD and depression were both recorded in one patient
only. Hearing loss was noticed in one patient. Brain (n=
13) and spinal (n= 9) imaging was mostly normal, except
for thinning of the corpus callosum in two (P12 and P13).
Interestingly, this was also observed in the reported family
with the same variant p.(Thr258Met) [13].
Three exceptions to the phenotype of pure HSP were
families P3, P8, and P24. The affected individuals from
families P3 and P8 had learning difficulties, with an IQ
varying from 68 to 80 points, where IQ below 70 is con-
sidered as borderline intellectual disability. In P24, the
patient had an intellectual disability (57 IQ points).
However, he had a de novo chromosome 2q37 contiguous
gene deletion including KIF1A and HDAC4 that very likely
explains the more complex phenotype.
Discussion
In conclusion, we report 24 probands with autosomal
dominant SPG with 20 heterozygous variants in KIF1A.
Three variants were recurrent in our cohort. SPG due to
KIF1A variants was rather pure. However, two families had
cognitive impairment, reflected by learning difficulties and
borderline intellectual disability in one patient, whereas one
additional proband had a complex phenotype and a de novo
contiguous gene deletion including KIF1A. Seventeen var-
iants in 20 families are likely to cause dominant SPG,
because they are missense variants in the kinesin domain
(11 variants, of which 5 had occurred de novo) or are very
likely loss-of-function variants outside the motor domain
(six variants, of which two were de novo). Three variants, in
four probands, are considered to be of uncertain significance
and would need further characterization. In addition, all
variants were absent or found only once (p.(Arg843Cys)) in
controls and affect evolutionary conserved amino acids in
alignments of orthologs. The presence of 20 likely disease
causing variants (or 24 including the variants of uncertain
significance) out of 347 families (6–7%) makes KIF1A a
frequent cause of autosomal dominant pure SPG.
Phenotypic differences in KIF1A related disease
Most variants in the allelic disorders associated with KIF1A
are located in the kinase motor domain suggesting a com-
mon molecular mechanism. The differences in disease
severity between autosomal dominant mental retardation
type 9, with a severe neurological involvement, and the
relative mild HSP in both recessive (SPG30) and dominant
forms is therefore intriguing. One explanation may be a
difference in the level of impairment of transport by KIF1A.
Kinesins are molecular motors involved in the transport
of cargo (e.g., organelles, proteins, mRNA) to their sites of
action. The motor domains of kinesins are involved in
binding and movement along microtubules, whereas other
Fig. 3 Schematic representation of the KIF1A protein with all variants
in the allelic disorders. All variants identified in spastic paraplegia are
depicted above the schematic protein in red open triangles (autosomal
dominant) or blue solid triangles (autosomal recessive), while variants
in mental retardation type 9 and hereditary sensory neuropathy IIC are
shown below the schematic in green open diamonds and purple solid
dots, respectively. Protein domains are according to UniProt con-
sortium (https://www.uniprot.org)



























































































































































































































































































































































































































































































































































































































































































































































































































46 M. Pennings et al.
domains of the kinesins are involved in cargo binding or
cargo-induced dimerization [19, 20]. KIF1A is almost
exclusively expressed in the brain and spinal cord [21] and
RNA-sequencing data of human tissues reveals high
expression in cerebral cortex, hippocampus, hypothalamus,
cerebellum, caudate, and pituitary gland [22]. KIF1A is
involved in anterograde transport of vesicles in neuronal
axons [23, 24] and it is hypothesized that mild transport
impairment may only affect the long axons to the legs and
the bladder, resulting in SPG. In contrast, strongly impaired
transport will also affect neurons more proximally, leading
to more severe motor deficits, and possibly also to invol-
vement of other neuronal populations that lead to mental
impairment [5]. The difference between a dominant and
recessive inheritance of SPG due to KIF1A variants may
likewise be a result of subtle differences in the efficiency of
the delivery of cargo to the periphery of the motor neurons.
Another possibility is that there is some redundancy in
the expression of different kinesins, such as the kinesin1,
−2, −3, −4, −11, and −13 family members [25]. In
affected neuronal populations, some of these other kinesins
may possibly compensate for ‘mild’ KIF1A variants only. In
other brain regions that express KIF1A but are unaffected,
even in the severe mental retardation type 9, such com-
pensation by other kinesins may be sufficient for normal
function. These mechanisms, however, are yet speculative
and need further molecular assessments.
Patients of two families had learning difficulties, and one
had borderline intellectual disability. Possibly, these mild
cognitive impairments may be attributed to the KIF1A
variants. As such, pure SPG and mental retardation type 9
may be the two extremes of one disease spectrum, where the
two families with learning disabilities are intermediates.
However, mild cognitive impairment, such as learning dif-
ficulties, is relatively common in the general population and
was also seen in some family members not having the
KIF1A variant. More cases with KIF1A variants and this
intermediate phenotype need to be discovered before a
causal relationship may be assigned.
2q37 microdeletion syndrome/brachydactyly-
mental retardation syndrome
The KIF1A gene is located in the cytogenetic 2q37.3
band, and is deleted in a subset of the 2q37 microdeletion
syndrome patients. This microdeletion syndrome is char-
acterized by mental retardation (in most), brachydactyly
(in 50%), short stature, obesity, hypotonia, characteristic
facial appearance, autism spectrum disorder (in 30%),
seizures (in 20–35%), and many other congenital
anomalies [26]. Inactivating variants in the HDAC4 gene
in patients without the 2q37 microdeletion, but with bra-
chydactyly and mental retardation, suggested that the
HDAC4 gene is the cause of these two features in the 2q37
microdeletion syndrome [27]. Other genes are likely
involved in other characteristics of this syndrome. Spas-
ticity has been reported in decipher in one of the patients
(ID 250622) having a 2q37 microdeletion involving
KIF1A, but not in others. This may be due to the under-
diagnosis of SPG in children with severe other neurolo-
gical problems, or due to a masking of SPG due to
hypotonia, which is another frequent finding in the 2q37
microdeletion syndrome. In proband P24, the major pro-
blem was SPG, although he was also diagnosed with mild
mental retardation and later developed seizures, both
likely attributable to haploinsufficiency of HDAC4.
Reversed phenotyping in a large set of patients with the
2q37 microdeletion syndrome may reveal whether SPG is
a commonly overlooked feature, or whether the pene-
trance of SPG in this syndrome is also incomplete.
Molecular mechanisms of missense variants in the
kinesin motor domain
The anterograde transport of KIF1A motor domain mutants
in dominant mental retardation type 9 and, to a lesser extent,
in SPG30 was previously found to be impaired, and thereby
resulted in decreased localization of KIF1A in distal axons
[5, 6]. Therefore, it is anticipated that cargo is still bound by
KIF1A, but delivered with reduced speed and numbers at
the neuronal distal axons, and that this mechanism is more
pronounced in dominant mental retardation type 9 than in
recessive SPG30 [5, 6].
The subcellular localization of the KIF1A mutants in
dominant SPG has not been analyzed. Nevertheless, we
speculate that the anterograde transport of motor domain
mutants in autosomal dominant SPG (17 motor domain
variants of 26 total, Fig. 1) is also impaired. The fact that
they cause a milder disease than the variants in dominant
mental retardation type 9, suggest that the transport deficit of
the dominant SPG mutants is an intermediate between
dominant mental retardation type 9 and recessive SPG30,
where both copies of the gene are mutated in the latter dis-
order. The suggestion of a variant-specific ‘dose-effect’ is
corroborated by the fact that there is no overlap between the
variants found in dominant SPG and those in dominant
mental retardation type 9 or recessive SPG30. More speci-
fically, some variants in dominant SPG (p.(Gly102Ser);
p.(Arg350Trp); p.(Arg167His); Fig. 1) affect the same amino
acid, but result in a different substitution compared with
variants in recessive SPG (p.(Arg350Gly)) [9, 10] or domi-
nant mental retardation type 9 (p.(Gly102Asp); p.(Arg167-
Cys)) [5]. This proposed relation between variants and
their respective allelic disorder indicates that the phenotypic
differences are caused by the KIF1A variants themselves,
rather than by other genetic or environmental factors.
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Molecular mechanisms of KIF1A loss-of-function
variants
Six of the KIF1A variants are likely loss-of-function var-
iants (nonsense, frameshift, and a gene deletion (Chr2q37))
located outside the kinesin motor domain. Two of those
had occurred de novo, and three others were present in
multiple affected family members. The low occurrence of
loss-of-function variants in KIF1A in controls has led to a
‘loss-of-function intolerance’ (pLI) probability score of
1.00 (on a 0.00–1.00 scale; gnomAD [13]). Moreover, no
loss-of-function variants were detected in our in-house
database of >30,000 exomes of patients or parents without
SPG. Nevertheless, even though the inheritance seems de
novo dominant, additional Sanger sequencing of the KIF1A
gene in these patients was performed to exclude the pos-
sibility of a recessive inheritance. Finally, heterozygous
KIF1A knockout mice develop neuropathy at older age,
indicating that KIF1A haploinsufficiency leads to a neu-
rological phenotype [28]. Together, these data suggests that
the six loss-of-function variants in KIF1A are likely the
cause of dominant SPG in these families. In contrast to the
variants in the motor domain, loss-of-function variants will
not result in an impaired transport of KIF1A itself, but
rather a reduced expression of KIF1A in neurons due to
nonsense-mediated decay of the variant mRNA, or due to
complete absence of transcription of the deleted allele. As a
consequence, it is anticipated that decreased levels of
KIF1A may result in reduced transport of cargo to the
periphery of the neuronal axons, not due to slow transport
by motor domain mutants, but because of shortage of
KIF1A motors.
Missense KIF1A variants outside the kinesin motor
domain
Four KIF1A variants detected in patients with dominant
SPG, three in this report and one described earlier [12],
reside outside the motor domain and are more difficult to
interpret. These variants are not present in a predicted
protein domain, except for p.(Ala460Gly), which may be
present in the major coiled-coil domain involved in
dimerization of KIF1A [19, 20]. In addition, these variants
are substitutions of conserved amino acids and are absent
from or extremely rare in large control databases (ExAC
and in-house database of >25,000 exomes). Unfortunately,
segregation analyses were not sufficient for these four
missense variants to prove their role in dominant SPG.
Identification of these variants in other individuals or
functional characterization of the mutant kinesins transport
characteristics may determine their role in SPG in the
future. In summary, we identified heterozygous causative
variants in the KIF1A gene in 6–7% of patients with auto-
somal dominant SPG. These variants were not only mis-
sense variants in the motor domain of KIF1A, as seen in
allelic disorders, but also loss-of-function variants outside
this domain. Haploinsufficiency is thus a likely pathogenic
mechanism for at least some of the KIF1A variants in
autosomal dominant SPG.
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